Verseon Interim Report Charts Progress of Development Programs as It Submits Phase I Protocol for Precision Anticoagulant
FREMONT, Calif.--(BUSINESS WIRE)--Verseon’s drug discovery program, based on an industry-leading in silico platform, progresses four programs with multiple novel compounds.